Treatment of allergic airways disease with an ti- IgE

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue SUPPL. 45, 1998, Pages 83-88

  Holgate, S T ^a   Corne, J ^a   Jardied, P ^b   Fick, R B ^a   Heusser, C H ^c  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b GENENTECH INC   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGENICITY; AMINO TERMINAL SEQUENCE; ATOPY; BINDING AFFINITY; CONFERENCE PAPER; DENDRITIC CELL; HYPERSENSITIVITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNITY; MAST CELL; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; HUMANS; IMMUNOGLOBULIN E; RESPIRATORY HYPERSENSITIVITY;

EID: 0031670214     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04946.x     Document Type: Conference Paper

References (63)

1. Prausnitz C, Kustner H. Studien uber Uberempfindlichkeit. Cent Bakterol 1921;86:160.
2. Johannson SGO, Bennick H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 1967;13: 3 81-94.
3. Ishizaka K, Ishizaka T Identification of gamma-E antibodies as a carrier of reagenic activity. J Immunol 1967;99: 1187.
4. Metzyer H, Kinet JP, Perez-Montfort R, et al. A tetrameric model for the structure of the mast cell receptor with high affinity for IgE. Prog Immunol 1983;5:493-508.
5. Sutton BJ, Gould HJ. The human IgE network. Nature 1993;366:42108.
6. Montefort S, Gratziou C, Goulding D, et al. Bronchial biopsy evidence for leucocyte infiltration and upregulation of leucocyte endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitised asthmatic airway. J Clin Invest 1994;93:1411-21.
7. Semper AE, Hartley JA. Dendritic cells in the lung - what is their relevance to asthma? Clin Exp Allergy 1996;26: 485-90.
8. Helm BA, Sayers I, Higginbottom A, et al. Identification of the high affinity receptor binding region in human immunoglobulin E. J Biol Chem 1996;27:7494-7500.
9. Heusser C, Jardieu P. Therapeutic potential of anti-IgE antibodies. Curr Opin Immunol 1997;9:805-14.
10. Hook WA, Berenstein E, Basciano LA, Fox PC, Siraganian RP. Monoclonal antibodies to human IgE [Abstractj. Fed Proc 1981;40:968(A4177).
11. Baniyash M, Eshhar Z. Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur J Immunol 1984;14:799-807.
12. Heusser CH, Bews J, Brinkmann V et al. New concepts of IgE regulation. Tnt Arch Allergy Appi Immunol 1991;94: 87-90.
13. Baniyash M, Kehry M, Eshhar Z. Anti-IgE monoclonal antibodies directed at the Fe receptor binding site. Mol Immunol 1988;25:705-11.
14. Magnusson CGM, Johansson SGO. Clinical significance of IgE autoantibodies and immune complexes containing IgE. Clin Rev Allergy 1989;7:73-103.
15. Czech W, Stadler BM, Schopf E, Kapp A. IgE auto- antibodies in atopic dermatitis - occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE. Allergy 1995:50:243-8.
16. Yu Y, de Week AL,. Stadler BM, Muller U. Anti-IgE autoantibodies and bee sting allergy. Allergy 1995;50: 119-25.
17. Presta L, Lahr S, Shields R, et al. Humanization of an antibody directed against immunoglobulin E. J Immunol 1993:151:2623-32.
18. Tong U, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AR. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997;99:461-5.
19. Stadler BM, Rudolf MP, Zurcher A\V, Miescher 5, Vogel M. Anti-IgE in allergic sensitization. Immunol Cell Biol 1996; 74:195-200.
20. Chang TW, Davis FM, Sun NC, Sun CRY, MacGlashan DW, Hamilton RG. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgEmediated allergic diseases. Biol Technol 1990:8:122-6.
21. Peng C, Davis FM, Sun LK, Liou RS, Kim YW, Chang TW. A new isoform of human membrane-bound IgE. J Imniunol 1992;148:129-36.
22. Presta L, Shields R, O'Connell L, et al. The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem 1994;269:26368-73.
23. Bozelka BE, McCants ML, Salvaggio JE, Lehrer SB. IgE isotype suppression in anti-c treated mice. Immunology 1982;46:527-32.
24. Bozelka BE, McCants ML, Salvaggio JE, Lehrer SB. Effects of anti-c on total and specific IgE levels in adult mice. mt Arch Allergy Appl Immunol 1985:78:51-6.
25. Haba 5, Nisonoff A. Effects of syngeneic anti-IgE antibodies on the development of IgE memory and on the secondary IgE response. J Immunol 1994;152:51-7.
26. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL- 4 induced Th2 responses and IgE class switching in mice with disrupted STAT 6 gene. Nature 1996;380:630-3.
27. Haba 5, Nisonoff A. Role of antibody and T cells in the long term inhibition of IgE synthesis. Proc Natl Acad Sci U S A 1994;91:604-8.
28. Haak-Frendscho M, Robbins K, Lyon R, et al. Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo. Immunology 1994;82:306-13.
29. Paul WE. Interleukin 4: signalling mechanisms and control of T cell differentiation. Ciba Found Symp 1997;204: 208-16.
30. Hamburger RN. Inhibition of IgE binding to tissue culture cells and leukocytes by pent apeptide. Immunology 1979:38: 781-2.
31. Burt SD, Stanworth DR. Inhibition of binding of rat IgE to rat mast cells by synthetic IgE peptides. Eur J Immunol 1987;17:437-40.
32. Davis FM, Gossett LA, Pinkston KL, et al. Can anti-IgE be used to treat allergy? Springer Semin Immunopathol 1993;15:51-73.
33. Heusser CH, Wagner K, Bews JP, et al. Demonstration of the therapeutic potential of non-Anaphylactic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation. Tnt Arch Allergy Immunol 1997:113:231-5.
34. Coyle Al, LeGros G, Bertrand C, et al. IL-4 is required for the induction of lung Th2 mucosal immunity. Respir Cell Mol Biol 1995;13:54-9.
35. Nakajima H, Iwamoto I, Tomoe S. et al. CD4+ lymphocytes and interleukin-5 mediate antigen induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;144:374-9.
36. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser CH. Central role of immunoglobulin E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-Anaphylactogenic anti-IgE antibody. J Exp Med 1996;183:1303-10.
37. Kehry MR, Yamashita LC. Low affinity IgE receptor (CD23) function on mouse B cells: role in IgE dependent focusing. Proc Natl Acad Sci U S A 1989:86:7556-60.
38. Coyle AJ, Eum S-Y, Lefort J, Heusser C, Vargaftig B. Central role of IgE in antigen induced bronchoconstriction, eosinophil accumulation and airway hyperreactivity: inhibition by a non-Anaphylactogenic anti-IgE inonoclonal antibody [Abstract]. Am J Respir Crit Care Med 1996; 153:A217.
39. Saban R, Haak-Frendscho M, Zine M, et al. Human FcER1- IgG and humanized anti-IgE monoclonal antibody MAE11 block passive sensitization of human and rhesus monkey lung. J Allergy Clin Immunol 1994;94:836-43.
40. Rabe K, Watson N, Dent G, et al. Inhibition of human airway sensitization by a novel monoclonal anti-IgE antibody 17-9. Am J Respir Crit Care Med 1998;157:1429-35.
41. Marshall JS, Wells PD, Bell EB. Accelerated elimination of N brasiliensis from the small intestine after auto-Anti-IgE induction. Immunology 1987;60:303-8.
42. Amiri P Haak-Frendscho M, Robbins K, McKerrow JH, Stewart T, Jardieu P Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon knockout mice. 3 Exp Med 1994;180:43-51.
43. Kolbinger F, Saldanha J, Hardman N, Mendig MM. Humanization of a mouse anti-human IgE antibody: a potential therapeutic for IgE-mediated allergies. Protein Eng 1993;6:971-80.
44. Reichmann L, Clark M, Waldmann H, Winter 0. Reshaping human antibodies for therapy. Nature 1988;332: 323-7.
45. Jones FL Dear PH, Foote 3, Neuberger MS, Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 1986; 321:522-5.
46. Carter P, Presta L, Gorman CM, et al. Humanization of an anti-p185 HER2 antibody for human cancer therapy. Proc Nati Acad Sci U S A 1992;89:4285-9.
47. Haak-Frendscho M, Ridgway 3, Shields R, Robbins K, Gorman C, Jardieu P Human IgE receptor chain lgG chimera blocks passive cutaneous anaphylaxis reaction in vivo. 3 Immunol 1993;151:351-8.
48. Shields R, Werther W, Zioncheck K, et al. Inhibition of allergic reactions with antibodies to IgE. In: Galli S, Sheffer D, editors. Proceedings 20th Symposium Collegium Internationale Allergologicum. mt Arch Allergy Clin Immunol 1995;107(Suppl):308-12.
49. Fox IA, Hotaling TE, Struble C, Ruppel 3, Bates DI, Schoenhoff MB. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys. I Pharmacol Exp Ther 1996:279:1000-8.
50. Meng YG, Singh N, Wong WL. Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor. Mol Immunol 1996;33: 635-42.
51. Liu I, Lester P, Builder S, Shire SJ. Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE. Biochemistry 1995; 34:10474-82.
52. Fox IA, Hotaling TE, Struble C, Ruppel J, Bates DI, Schoenhoff MB. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration of cynomolgus monkeys. I Pharmacol Exp Ther 1996;279:1000-8.
53. Come J, Djukanoviã R, Thomas L, et al. The effect of intravenous administration of a chimaeric anti-IgE antibody on serum IgE levels in atopic subjects - efficacy, safety and pharmacokinetics. J Clin Invest 1997;99:879-87.
54. Boulet LP, Chapman KR, Cote J, et al. Inhibitory effects of an anti-IgE antibody E-25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997:155: 1835-40.
55. Fahy JV, Fleming HE, Wong HH, et al. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am I Respir Crit Care Med 1997;155:1828-34.
56. Bousquet 3, Demoly P. Editorial. Anti-IgE therapy for asthma. Am J Respir Crit Care Med 1997;155:1825-7.
57. Zeiger RS, Fick RB, E-25 Study Group Investigators. AntiIgE (rhu mAb) treatment of the symptoms of moderate- severe allergic asthma [Abstract]. Ann Allergy Asthma Immunol 1998;80:1.
58. Metzger WJ, Fick RB, E-25 Study Group Investigators. Corticosteroid (CS) withdrawal in a study of recombinant humanized monoclonal antibody to IgE (rhu mAb-E25) [Abstract]. J Allergy Clin Inimunol 1998;101:S231.
59. Casale TB, Bernstein IL, Busse WW, et al. Use of an antiIgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-21.
60. Fahy JV, Cockcroft DW, Boulet LP, et al. Effect of aerosolized anti-IgE (E-25) on airway responses to inhaled allergen in asthmatic subjects [Abstract]. Am I Respir Crit Care Med 1998;157:A410.
61. Achilles K, Tin C, Mrsny R, Sweeny TD. Transport of an anti-IgE antibody (rhumAB E-25) across lung epithelium [Abstract]. Am J Respir Crit Care Med 1998;157:A730.
62. MacGlashan DW, Bochner BS, Adelman DC, et al. Down regulation of FceRl expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
63. Saini S, MacGlashan D Jr, Adelman D, Togias A, Lichtenstein LM, Bochner BS. Discontinuation of anti-IgE infusions restores basophil (BASO) IgE and FcR1, expression and IgE-dependent histamine release (HR) responses [Abstract]. I Allergy Clin Immunol 1998; 101 :437.